3D细胞文化市场[按产品类型（基于脚手架的平台，生物反应器，凝胶，微芯片和服务）;通过申请（药物发现，干细胞研究，癌症研究和再生医学）;通过最终用户（学术机构，生物技术和制药公司，以及合同研究实验室）;and By Regions (North America - U.S., Canada; Europe - Germany, UK, France, Italy, Russia; Asia-Pacific - China, India, Japan, Australia; Latin America - Brazil, Mexico; Middle East & Africa)]: Market size & Forecast, 2018 – 2026

报告摘要

2017年全球3D细胞文化市场规模估计为673.6百万美元，并预计未来几年将获得大量牵引力。3D细胞培养是一种与生物体分离的精确复制的环境，其中通过在其环境中相互关联，将细胞归于迁移以及增长。3D细胞培养培养组织组织组织和细胞分化的阶段，其在常规的2D细胞培养系统中不可持续。3D细胞培养具有更多的组织偏差和细胞结构性质。

3.D cell structures are gaining acceptance and have displayed augmented applications majorly in the early drug discovery and other research and development sector. This method is used by investigators to construct physiologically comparable cell culture stereotypes that support drug discovery and development. Persistent need to refine efficiency in pharmaceutical research and development is also encouraging the use of 3D cell cultures.

Growing investment by biotechnology as well as pharmaceutical corporations on 3D cell culture and growth in a number of patients in need for organ replacement are the key aspects enhancing the significant growth of the global 3D CC market. Moreover, the prohibition on the animal study and testing is also antic to drive the market across various applications. However, high initial investments may restrain the growth of the market. Additionally, expansion of 3D cell culture for conveying personalized cosmetics would deliver development opportunities for the global market during the forecast period.

细分分析

全球3D细胞文化市场份额在产品类型，应用程序，最终用户和地理基础上进行分割。

产品类型的基础上,全球市场share is segmented into Scaffold-based platforms, Bioreactors, Gels, Microchips, and Services. The scaffold based platforms are further categorized into Macro-Porous scaffolds, Microporous scaffolds, Nanoporous scaffolds, Scaffold free platforms, and Solid scaffolds. Scaffold-based cultures estimated to share the highest market in 2017. Availability of a substantial number of products based on the structure maintained 3D cell culture is attributive for the estimated share of this segment.

基于应用，全球市场被分段为药物发现，干细胞研究，癌症研究和再生医学。2017年，在癌症研究中的应用估计是对3D细胞文化市场的最大需求。在最终用户的基础上，全球3D CC市场被分段为学术机构，生物技术和制药公司，以及合同研究实验室。生物技术和制药部门在2017年占据了市场，这是对技术应用在药物发现程序中的应用，以便进行良好组织的筛查和董事会验证。

Regional Analysis

在地理方面，北美估计占据全球3D细胞文化市场。该地区的主导地位归因于存在与研究实验室联合的技术的许多药物和生物技术组织。然而，亚太地区预计将主导全球3D细胞文化市场。迅速发展的经济状况和对研发项目的需求不断增长是预期提高该地区市场增长的主要因素。此外，预计将在该地区以外运作的主要参与者的完整区域有望增强亚太地区的市场。

Competitive Landscape

Major firms are focusing on small firms with a working methodology of securing the end goal to manage position in the market and are associated with mergers and acquisitions, key joint efforts, and novel item advancement to pick up profit share in the business. Some major key players in global 3D Cell Culture Market includes 3D Biotek, Advanced Biomatrix, Becton and Dickinson Company (BD), corning Incorporated, Global cell solutions Inc., Thermo Fisher scientific Inc., VWR Corporation, Nanofiber solutions, Lonza Group Ltd., Synthecon incorporated, and Tecan Trading AG among others.